Akèy › Degeneresans makile › Kalifòni
Etid klinik pou Degeneresans makile nan Kalifòni
20 etid pou Degeneresans makile ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
- Sacramento8 etid
- Santa Monica7 etid
- Mountain View6 etid
- San Francisco5 etid
- Concord4 etid
- San Bernardino3 etid
- Oxnard3 etid
- Fullerton3 etid
- Pasadena3 etid
- Escondido3 etid
- Bakersfield3 etid
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Global Research Management, Inc., Glendale
- Retinal Consultants Medical Group (Site 024), Modesto
- Azul Vision / California Eye Specialists Medical Group, Inc., Pasadena
- ak 3 plis
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Consultants of Orange County, Fullerton
- Shiley Eye Institute Jacobs Retina Center, La Jolla
- California Retina Consultants, Oxnard
- ak 3 plis
Ap rekriteFaz 2/3
Laj 60 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- California Retina Consultants, Bakersfield
- Retina-Vitreous Associates Medical Group, Beverly Hills
Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Vitreous Associates Medical Group, Beverly Hills
- Retina Specialists of Beverly Hills- Department of Ophthalmology, Beverly Hills
- Eye Medical Center of Fresno, Fresno
- ak 19 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- California Retina Consultants, Bakersfield
- Retina-Vitreous Associates Medical Group, Beverly Hills
- Macula and Retina Institute, Glendale
- ak 4 plis
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Jules Stein Eye Institute, Los Angeles
- Stanford University Byers Eye Institute, Palo Alto
- Kaiser Permanente Riverside Medical Center, Riverside
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Consultants San Diego, Poway
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Stanford University School of Medicine, Palo Alto
- University of California Health - UC Davis, Sacramento
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- California Retina Consultants, Oxnard
- Retinal Consultants Medical Group, Sacramento
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Retina-Vitreous Associates Medical Group, Beverly Hills
- Bay Area Retina Associates, Walnut Creek
Ap rekriteFaz 2
Laj 55 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
- Retina Vision Consultants, Beverly Hills
- Palo Alto Medical Foundation, Palo Alto
- Retinal Consultants Medical Group, Sacramento
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07594236A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- The Retina Partners, Encino
- Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View
- Orange County Retina Medical Group, Santa Ana
Ap rekriteFaz 2/3
Laj 50 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 109, Bakersfield
- Adverum site 169, Fullerton
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07630649Effects of Goji vs. Fiber on Macular Degeneration
- UC Davis Eye Center, Tschannen Eye Institute, Sacramento
Ap rekriteVolontè an sante akeyi
Laj 65 a 95 · Tout sèks · Mizajou Jul 17, 2026 · NCT06237127Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
- Beverly Hills, CA, Beverly Hills
Ap rekriteFaz 1/2
Laj 50 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07587515Village-Integrated Eye Worker Trial II
- University of California, San Francisco, San Francisco
Ap rekriteVolontè an sante akeyi
Laj 60 ak plis · Tout sèks · Mizajou Jun 9, 2026 · NCT03752840Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 55 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT07556406Strategies for Improving Linkage-to-Care After Eye Disease Screening
- University of California, San Francisco, San Francisco
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT06943599Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retinal Diagnostic Center, Campbell
- Retina Consultants of Orange County, Fullerton
- Northern California Retina Vitreous Associates, Mountain View
- ak 4 plis
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT07064759Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Loma Linda University, Loma Linda
- Eye Physicians of Long Beach, Long Beach
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Dec 3, 2024 · NCT05438732Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.